DUPIXENT vs EBGLYSS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. DUPIXENT and EBGLYSS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DUPIXENT	EBGLYSS
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DUPILUMAB	LEBRIKIZUMAB-LBKZ
Manufacturer	Regeneron Pharmaceuticals	Eli Lilly and Co
Dosage forms	Injectable	Injectable
Drug class	Interleukin-4 Receptor Alpha Antagonist	—
Boxed warning	None	None
Treats	Atopic Dermatitis	Atopic Dermatitis

dupixent ebglyss

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

DUPILUMAB

LEBRIKIZUMAB-LBKZ

Manufacturer

Regeneron Pharmaceuticals

Eli Lilly and Co

Dosage forms

Injectable

Drug class

Interleukin-4 Receptor Alpha Antagonist

—

Boxed warning

None

Treats

Atopic Dermatitis

Frequently asked questions

What is the difference between Dupixent and Ebglyss?

Dupixent contains Dupilumab, while Ebglyss contains Lebrikizumab-Lbkz — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.